heme has been researched along with Cardiotoxicity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fawzy, MA; Refaie, MMM; Rifaai, RA; Shehata, S | 1 |
| Abe, K; Furusawa, S; Ide, T; Ikeda, M; Imai, H; Ishimaru, K; Koumura, T; Matsushima, S; Miyake, R; Miyamoto, HD; Tadokoro, T; Tsutsui, H; Tsutsui, Y; Watanabe, M; Yamada, KI | 1 |
| Gao, J; Peng, J; Teng, H; Wang, Z | 1 |
3 other study(ies) available for heme and Cardiotoxicity
| Article | Year |
|---|---|
Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cadmium; Cardiotoxicity; Environmental Pollutants; Glutathione; Glutathione Peroxidase; Heme; Interleukin-6; Male; Malondialdehyde; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Signal Transduction; Toll-Like Receptor 2; Tumor Necrosis Factor-alpha | 2022 |
Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis.
Topics: Aminolevulinic Acid; Animals; Cardiotoxicity; DNA, Mitochondrial; Doxorubicin; Ferroptosis; Heme; Iron; Iron Overload; Mice; Mitochondria; Myocytes, Cardiac | 2022 |
Effects of Doxorubicin on Heme Biosynthesis and Metabolism in Cardiomyocyte.
Topics: 5-Aminolevulinate Synthetase; Cardiotoxicity; Doxorubicin; Heme; Humans; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species | 2021 |